E6/E7 mRNA Expression of High-risk HPV Types in 849 Greek Women

被引:4
|
作者
Argyri, Elena [1 ]
Tsimplaki, Elpida [1 ]
Daskalopoulou, Dimitra [2 ]
Stravopodis, Dimitrios J. [4 ]
Kouikoglou, Ourania [1 ]
Terzakis, Emmanouil [3 ]
Panotopoulou, Efstathia [1 ]
机构
[1] St Savvas Reg Anticanc Oncol Hosp Athens, Dept Virol, Athens 11522, Greece
[2] St Savvas Reg Anticanc Oncol Hosp Athens, Dept Cytopathol, Athens 11522, Greece
[3] St Savvas Reg Anticanc Oncol Hosp Athens, Dept Gynaecol 2, Athens 11522, Greece
[4] Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens, Greece
关键词
HPV; E6; E7; Greece; HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL-CANCER; PREVALENCE; E6; TRANSCRIPTS; WORLDWIDE; AGE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: The goal of this study was to investigate human papillomavirus (HPV) geno typing and high-risk HPV E6/E7 mRNA expression in 849 women. Patients and Methods: 849 Cervical samples were obtained from patients attending an outpatient clinic to have their annual gynaecological check-up. All patients underwent a conventional Pap test. The patients were also offered HPV test with the knowledge that it is not part of the screening. Results: Overall prevalence of HPV DNA was 41.3%, while E6/E7 mRNA expression was found in 20.7% of the patients. HPV DNA and E6/E7 mRNA expression were detected in 21.1% and 9.1% of normal cytological samples, respectively, 38.1% and 23.8% of atypical squamous cells of unknown significance, 84.8% and 40.7% of low-grade squamous intraepithelial lesions, and 96.4% and 89.3% of high-grade squamous intraepithelial lesions, respectively. HPV 16 was the most frequent genotype identified. Conclusion: E6/E7mRNA detection might be useful as a screening marker for the early prediction of active infections and subsequent progression to severe dysplasia.
引用
收藏
页码:4007 / 4011
页数:5
相关论文
共 50 条
  • [1] High-risk HPV E6/E7 mRNA in situ expression in cervical premalignant lesions
    Benedetti, I.
    Barrios, L.
    Rodriguez, R.
    VIRCHOWS ARCHIV, 2024, 485 : S83 - S84
  • [2] Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS
    Xiu Jin
    Feifei Liu
    Ya Zhang
    Yingying Ma
    Linqing Yang
    Yunfei Wang
    Ying Liu
    BMC Women's Health, 23
  • [3] Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS
    Jin, Xiu
    Liu, Feifei
    Zhang, Ya
    Ma, Yingying
    Yang, Linqing
    Wang, Yunfei
    Liu, Ying
    BMC WOMENS HEALTH, 2023, 23 (01)
  • [4] E6/E7 mRNA Expression of the Most Prevalent High-Risk HPV Genotypes in Cervical Samples from Serbian Women
    Nikolic, Natasa
    Basica, Branka
    Mandic, Aljosa
    Surla, Nela
    Gusman, Vera
    Medic, Deana
    Petrovic, Tamas
    Strbac, Mirjana
    Petrovic, Vladimir
    DIAGNOSTICS, 2023, 13 (05)
  • [5] Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
    Ying Liu
    Xiu Jin
    Yingying Gong
    Yingying Ma
    Beibei Du
    Linqing Yang
    Yunfei Wang
    Weipei Zhu
    Infectious Agents and Cancer, 18
  • [6] Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
    Liu, Ying
    Jin, Xiu
    Gong, Yingying
    Ma, Yingying
    Du, Beibei
    Yang, Linqing
    Wang, Yunfei
    Zhu, Weipei
    INFECTIOUS AGENTS AND CANCER, 2023, 18 (01)
  • [7] A COHORT RETROSPECTIVE STUDY OF THE HIGH-RISK HPV RECURRENCE IN GREEK WOMEN AFTER CERVICAL LESION TREATMENT THROUGH DETECTION OF VIRAL E6/E7 MRNA EXPRESSION
    Carcea, F.
    Daniilidis, A.
    Vavoulidis, E.
    Nasioutziki, M.
    Papanikolaou, A.
    Dinas, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A208 - A209
  • [8] A cohort retrospective study of high-risk HPV recurrence in Greek women after cervical lesion treatment through detection of viral E6/E7 mRNA expression
    Carcea, Fausto
    Daniilidis, Angelos
    Vavoulidis, Eleftherios
    Nasioutziki, Maria
    Papanikolaou, Alexios
    Dinas, Konstantinos
    JOURNAL OF BUON, 2020, 25 (01): : 99 - 107
  • [9] THE CARCINOGENIC POTENTIAL OF E6 & E7 GENES OF HIGH-RISK HPV COMPARED WITH E6, E7 GENES OF LOW-RISK HPV IN HUMAN CERVICAL CANCER: A REVIEW
    Gill, Sher Singh
    Jana, A. M.
    Shrivastav, Archana
    Sharma, Sachin
    Sharma, Arvind
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2014, 5 (03): : 703 - 712
  • [10] A Comparative Evaluation of HPV OncoTect E6 E7 mRNA and Cervista HPV 16/18 Tests on High-Risk HPV Samples
    Noy, M. A.
    Paz, J. R.
    Rosado, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 872 - 873